Daniel Esgardo Rangel Barón: New Serious Adverse Effects With Alemtuzumab in MS

Several new and potentially life-threatening adverse events associated with the use of this novel agent for multiple sclerosis have been reported.
Medscape Medical News
View Source

Related Post